Pages that link to "Q38062266"

The following pages link to Melt extrusion with poorly soluble drugs (Q38062266):

Displaying 41 items.

• Fundamental aspects of solid dispersion technology for poorly soluble drugs (Q26822873) (← links)
• Extrusion - back to the future: Using an established technique to reform automated chemical synthesis (Q28817217) (← links)
• A study on the impact of hydroxypropyl methylcellulose on the viscosity of PEG melt suspensions using surface plots and principal component analysis. (Q35209961) (← links)
• Mefenamic acid taste-masked oral disintegrating tablets with enhanced solubility via molecular interaction produced by hot melt extrusion technology (Q35505617) (← links)
• Influence of Molecular Weight of Carriers and Processing Parameters on the Extrudability, Drug Release, and Stability of Fenofibrate Formulations Processed by Hot-Melt Extrusion (Q36343942) (← links)
• Conjugation of Hot-Melt Extrusion with High-Pressure Homogenization: a Novel Method of Continuously Preparing Nanocrystal Solid Dispersions (Q36614773) (← links)
• Interactions between drugs and polymers influencing hot melt extrusion. (Q38170190) (← links)
• Physical stabilization of low-molecular-weight amorphous drugs in the solid state: a material science approach. (Q38257177) (← links)
• Granulation techniques and technologies: recent progresses (Q38435033) (← links)
• Hot-Melt Extrusion: from Theory to Application in Pharmaceutical Formulation (Q38544558) (← links)
• Development of Tablet Formulation of Amorphous Solid Dispersions Prepared by Hot Melt Extrusion Using Quality by Design Approach (Q38619405) (← links)
• Investigation of Thermal and Viscoelastic Properties of Polymers Relevant to Hot Melt Extrusion, IV: Affinisol™ HPMC HME Polymers (Q38619454) (← links)
• Hot Melt Extrusion: Development of an Amorphous Solid Dispersion for an Insoluble Drug from Mini-scale to Clinical Scale (Q38619531) (← links)
• Optimising Drug Solubilisation in Amorphous Polymer Dispersions: Rational Selection of Hot-melt Extrusion Processing Parameters (Q38619541) (← links)
• Hot melt extrusion as an approach to improve solubility, permeability and oral absorption of a psychoactive natural product, piperine (Q42433654) (← links)
• Wetting Kinetics: an Alternative Approach Towards Understanding the Enhanced Dissolution Rate for Amorphous Solid Dispersion of a Poorly Soluble Drug (Q42646407) (← links)
• Effect of composition in the development of carbamazepine hot-melt extruded solid dispersions by application of mixture experimental design (Q43728136) (← links)
• Evaluation of the recrystallization kinetics of hot-melt extruded polymeric solid dispersions using an improved Avrami equation (Q45326562) (← links)
• Lipid nanoparticles for administration of poorly water soluble neuroactive drugs. (Q48034195) (← links)
• Hot melt extruded Aprepitant-Soluplus solid dispersion: preformulation considerations, stability and in vitro study (Q48062570) (← links)
• Pharmaceutical development of an amorphous solid dispersion formulation of elacridar hydrochloride for proof-of-concept clinical studies (Q48384525) (← links)
• Co-extrusion as a processing technique to manufacture a dual sustained release fixed-dose combination product (Q49083280) (← links)
• Study the influence of formulation process parameters on solubility and dissolution enhancement of efavirenz solid solutions prepared by hot-melt extrusion: a QbD methodology. (Q50090792) (← links)
• Melt extrusion with poorly soluble drugs - An integrated review (Q50161058) (← links)
• Continuous low-dose feeding of highly active pharmaceutical ingredients in hot-melt extrusion (Q51566498) (← links)
• Development of Fast-Dissolving Amorphous Solid Dispersion of Itraconazole by Melt Extrusion of its Mixture with Weak Organic Carboxylic Acid and Polymer. (Q52562383) (← links)
• Increased dissolution rates of carbamazepine--gluconolactone binary blends processed by hot melt extrusion. (Q53295583) (← links)
• A Novel Approach for the Development of a Nanostructured Lipid Carrier Formulation by Hot-Melt Extrusion Technology. (Q53784974) (← links)
• Preparation, characterizations and anti-pollutant activity of 7,3′,4′-trihydroxyisoflavone nanoparticles in particulate matter-induced HaCaT keratinocytes. (Q55109237) (← links)
• Effects of Surfactants on Itraconazole-HPMCAS Solid Dispersion Prepared by Hot Melt Extrusion. I: Miscibility and Drug Release (Q58617159) (← links)
• Hot Melt Extrusion as Solvent-Free Technique for a Continuous Manufacturing of Drug-Loaded Mesoporous Silica (Q60511161) (← links)
• Amorphisation of Free Acid Ibuprofen and Other Profens in Mixtures with Nanocellulose: Dry Powder Formulation Strategy for Enhanced Solubility (Q64250047) (← links)
• Hot Melt Extrusion: Highlighting Physicochemical Factors to Be Investigated While Designing and Optimizing a Hot Melt Extrusion Process. (Q64890565) (← links)
• Investigation of Polymer-Surfactant and Polymer-Drug-Surfactant Miscibility for Solid Dispersion (Q87666677) (← links)
• Exploring the Complexity of Processing-Induced Dehydration during Hot Melt Extrusion Using In-Line Raman Spectroscopy (Q89552029) (← links)
• Advances in coamorphous drug delivery systems (Q91603846) (← links)
• Tuning Drug Release via Twin Screw Extrusion in Polyester Films (Q92240713) (← links)
• Advanced Lipid Technologies® (ALT®): A Proven Formulation Platform to Enhance the Bioavailability of Lipophilic Compounds (Q92279311) (← links)
• Revealing Polymorphic Phase Transformations in Polymer-Based Hot Melt Extrusion Processes (Q92340329) (← links)
• A Mechanistic Model for Predicting the Physical Stability of Amorphous Solid Dispersions (Q98578693) (← links)
• Potential of solid dispersions to enhance solubility, bioavailability, and therapeutic efficacy of poorly water-soluble drugs: newer formulation techniques, current marketed scenario and patents (Q102150751) (← links)